Biopharmaceutical Optimisation of β-Cyclodextrin Inclusion Compounds
- 1 January 1990
- journal article
- Published by Springer Science and Business Media LLC in Clinical Drug Investigation
- Vol. 2 (4), 29-36
- https://doi.org/10.1007/bf03258224
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Microcalorimetric and chromatographic investigations of the binding of some pyridine derivatives to cyclodextrinsJournal of Pharmaceutical and Biomedical Analysis, 1988
- High-performance liquid chromatographic analysis of piroxicam and its major metabolite 5′-hydroxypiroxicam in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Particle Size and Surface Area Distributions of Pharmaceutical Powders by Microcomputerized Mercury PorosimetryJournal of Pharmaceutical Sciences, 1984
- Inclusion Complexation of p-Hydroxybenzoic Acid Esters with α- and β-Cyclodextrins : Dissolution Behaviors and Antimicrobial ActivitiesYAKUGAKU ZASSHI, 1980
- Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with .ALPHA.- and .BETA.-cyclodextrins in powdered form.CHEMICAL & PHARMACEUTICAL BULLETIN, 1975
- Thermodynamics of binding of guest molecules to α- and β-cyclodextrinsJournal of the Chemical Society, Perkin Transactions 2, 1973
- Wettability of porous surfacesTransactions of the Faraday Society, 1944
- The Determination of Contact Angles from Measurements of the Dimensions of Small Bubbles and Drops. I. The Spheroidal Segment Method for Acute Angles.The Journal of Physical Chemistry, 1936